Proinflammatory Action of a New Electronegative Low-Density Lipoprotein Epitope

Proinflammatory Action of a New Electronegative Low-Density Lipoprotein Epitope

The electronegative low-density lipoprotein, LDL (−), is an endogenously modified LDL subfraction with cytotoxic and proinflammatory actions on endothelial cells, monocytes, and macrophages contributing to the progression of atherosclerosis. In this study, epitopes of LDL (−) wer...

Full description

Bibliographic Details
Main Authors:	Tanize do Espirito Santo Faulin, Soraya Megumi Kazuma, Gustavo Luis Tripodi, Marcela Frota Cavalcante, Felipe Wakasuqui, Cristiano Luis Pinto Oliveira, Maximilia Frazão de Souza Degenhardt, Jussara Michaloski, Ricardo José Giordano, Daniel Francisco Jacon Ketelhuth, Dulcineia Saes Parra Abdalla
Format:	Article
Language:	English
Published:	MDPI AG 2019-08-01
Series:	Biomolecules
Subjects:	atherosclerosis macrophages LDL oxidized LDL electronegative LDL danger-associated molecular pattern mimotope peptide phage display epitope mapping
Online Access:	https://www.mdpi.com/2218-273X/9/8/386

Similar Items

Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases
by: Liang-Yin Ke, et al.
Published: (2020-11-01)

Electronegative LDL Is Associated with Plaque Vulnerability in Patients with Ischemic Stroke and Carotid Atherosclerosis
by: Núria Puig, et al.
Published: (2023-02-01)

Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis
by: Chih-Sheng Chu, et al.
Published: (2020-07-01)

Presence of Ceramidase Activity in Electronegative LDL
by: Núria Puig, et al.
Published: (2022-12-01)

Can Electronegative LDL Act as a Multienzymatic Complex?
by: Sonia Benitez, et al.
Published: (2023-04-01)

Density distribution of electronegative LDL in normolipemic and hyperlipemic subjects
by: José Luis Sánchez-Quesada, et al.
Published: (2002-05-01)

The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation
by: Hiroyuki Itabe, et al.
Published: (2023-03-01)

Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study
by: Bo Zhang, et al.
Published: (2009-09-01)

Electronegative LDL Promotes Inflammation and Triglyceride Accumulation in Macrophages
by: Núria Puig, et al.
Published: (2020-03-01)

scFv-Anti-LDL(-)-Metal-Complex Multi-Wall Functionalized-Nanocapsules as a Promising Tool for the Prevention of Atherosclerosis Progression
by: Marcela Frota Cavalcante, et al.
Published: (2021-04-01)

Autoantibodies against modified low density Lipoprotein in patients with coronary heart disease and normal individuals
by: "Mohammadi R, et al.
Published: (2001-12-01)

Autoantibodies against modified low density Lipoprotein in patients with coronary heart disease and normal individuals
by: "Mohammadi R, et al.
Published: (2001-08-01)

Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease
by: Shahzada Amir, et al.
Published: (2012-07-01)

Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia
by: B.M. Schamberger, et al.
Published: (2000-05-01)

Lipids and lipoproteins may play a role in the neuropathology of Alzheimer’s disease
by: Omer Akyol, et al.
Published: (2023-11-01)

The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
by: Adam Hartley, et al.
Published: (2021-10-01)

Serum ox-LDL Level is Reduced with the Extent of Stenosis in Coronary Arteries
by: Mohammad Najafi, et al.
Published: (2013-05-01)

Serum ox-LDL Level is Reduced with the Extent of Stenosis in Coronary Arteries
by: Mohammad Najafi, et al.
Published: (2013-05-01)

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3
by: Mohamad Navab, et al.
Published: (2000-09-01)

Analytical capillary isotachophoresis of total plasma lipoproteins: a new tool to identify atherogenic low density lipoproteins
by: Gabriele Bittolo-Bon, et al.
Published: (1999-01-01)

Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development
by: Nataliya V. Mushenkova, et al.
Published: (2021-07-01)

Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2020-03-01)

Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2023-01-01)

A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids
by: Mohamad Navab, et al.
Published: (2001-08-01)

Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential
by: Chang-Feng Deng, et al.
Published: (2022-02-01)

Comparison of Estimated LDL Cholesterol Equations with Direct Measurement in Patients with Angiographically Confirmed Coronary Artery Disease
by: Boqun Shi, et al.
Published: (2022-10-01)

Antibodies against electronegative LDL inhibit atherosclerosis in LDLr-/- mice
by: D.M. Grosso, et al.
Published: (2008-12-01)

The Initial Human Atherosclerotic Lesion and Lipoprotein Modification—A Deep Connection
by: Michael Torzewski
Published: (2021-10-01)

A Novel Immunoassay for Malondialdehyde-Conjugated Low-Density Lipoprotein Measures Dynamic Changes in the Blood of Patients Undergoing Coronary Artery Bypass Graft Surgery
by: Samata S. Pandey, et al.
Published: (2021-08-01)

Oxidatively Modified LDL Suppresses Lymphangiogenesis via CD36 Signaling
by: Bhupesh Singla, et al.
Published: (2021-02-01)

Early diagnosis and treatments in childhood are associated with better prognosis in patients with familial hypercholesterolemia
by: Hayato Tada, et al.
Published: (2022-12-01)

Extracorporeal LDL-Cholesterol Elimination in the Treatment of Severe Familial Hypercholesterolemia
by: Milan Bláha
Published: (2003-01-01)

The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges
by: David R. Greaves, et al.
Published: (2009-01-01)

Synthetic nanoemulsion resembling a protein-free model of 7-ketocholesterol containing low density lipoprotein: In vitro and in vivo studies
by: Giovani M Favero, et al.
Published: (2010-01-01)

Which LDL Value Should Clinicians Look at?
by: Harshad Malve, et al.
Published: (2021-05-01)

Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
by: Na-Qiong Wu, et al.
Published: (2018-11-01)

The Effect of Moderate Intensity Fun Aerobic Gym on HDL-C and LDL- C on Overweight Women
by: Zanuar Bagus Saputro, et al.
Published: (2021-01-01)

Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery
by: Adam Hartley, et al.
Published: (2022-01-01)

Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screen
by: Diego Lucero, et al.
Published: (2022-01-01)

Methods on LDL particle isolation, characterization, and component fractionation for the development of novel specific oxidized LDL status markers for atherosclerotic disease risk assessment
by: Polyxeni Papadea, et al.
Published: (2023-01-01)